We are live on
!
Find out more
ECM
Everence Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+0.48%
1 Year Est. Return
+26.46%
3 Year Est. Return
+80.44%
5 Year Est. Return
+106.59%
10 Year Est. Return
+436.91%
AUM
$452M
AUM Growth
-$4.06M
(-0.89%)
Cap. Flow
-$1.04M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
443
New
25
Increased
18
Reduced
19
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flowserve
FLS
|
+$1.05M |
| 2 |
American Airlines Group
AAL
|
+$943K |
| 3 |
Aptiv
APTV
|
+$438K |
| 4 |
Baker Hughes
BKR
|
+$433K |
| 5 |
Kraft Heinz
KHC
|
+$425K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$701K |
| 2 |
Simon Property Group
SPG
|
+$668K |
| 3 |
Comcast
CMCSA
|
+$643K |
| 4 |
Nektar Therapeutics
NKTR
|
+$606K |
| 5 |
PepsiCo
PEP
|
+$507K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.36% |
| 2 | Financials | 17.3% |
| 3 | Healthcare | 15.08% |
| 4 | Communication Services | 10.39% |
| 5 | Consumer Discretionary | 10.04% |
Similar funds
LIA
GA
AHC
UMC
1SP
MRG
TCA
Everence Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Everence Capital Management held 443 positions worth $452M, down 0.89% from $456M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Everence Capital Management's Q1 2018 filing shows 25 new, 18 increased, 19 reduced and 20 closed positions. Its largest new stake was Flowserve: 24,000 shares worth $1.04M. The largest sale was Apple, an estimated $701K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Everence Capital Management's largest Q1 2018 buy was Flowserve: 24,000 shares worth $1.04M.
- Everence Capital Management added most to Baker Hughes in Q1 2018, an estimated $433K increase.
- Everence Capital Management's biggest Q1 2018 reduction was Apple, cutting an estimated $701K.
- Everence Capital Management fully exited Nektar Therapeutics in Q1 2018, selling an estimated $606K.
- Everence Capital Management's ten largest holdings make up 22% of its $452M portfolio in Q1 2018.
- Everence Capital Management opened 25 new positions and closed 20 in Q1 2018.
- Everence Capital Management's portfolio value fell 0.89% quarter-over-quarter to $452M.
Based on Everence Capital Management's 13F filing for Q1 2018, filed 30 Apr 2018.